NIH Grants Biotech Firm Monopoly on Cutting-Edge Cancer Detection Tech
Published Date: 11/19/2025
Notice
Summary
The National Institutes of Health plans to give BioncoDx, LLC an exclusive license to use special methods for diagnosing and predicting cancer. This means BioncoDx will have the sole right to develop and sell these cancer-related technologies. If you want to comment or apply for a license, you need to act by December 4, 2025.
Analyzed Economic Effects
3 provisions identified: 1 benefits, 2 costs, 0 mixed.
Exclusive Urine-Based Cancer Test License
The NIH plans to grant BioncoDx, LLC an exclusive license to develop, manufacture, and commercialize Food and Drug Administration (FDA) premarket approval tests that use four urine biomarkers—creatine riboside, metabolite 561+, cortisol sulfate, and N-acetylneuraminic acid—to detect and prognose cancers (examples listed include lung, breast, colorectal, kidney/bladder, prostate, liver, stomach, pancreatic, GYN, and brain). The notice describes this technology as a unique, non-invasive screening and diagnostic tool that can detect cancers at an early stage using urine samples and that urine sampling minimizes patient discomfort compared with invasive methods.
Sole Commercial Rights for BioncoDx
The prospective license would give BioncoDx the sole (exclusive) right to practice the listed patent rights worldwide where patent rights exist for the specified field of use: developing, manufacturing, and commercializing FDA PMA tests using the named biomarkers for screening/diagnosing the listed cancers. After a negotiated period, the exclusive field of use will be reduced to a subset of three cancer indications and will include strict developmental benchmarks for each indication.
Prospective License Will Be Royalty‑Bearing
The notice states the prospective exclusive license will be royalty-bearing. The notice also states that the license may be granted unless, within fifteen (15) days from the date of the published notice, the National Cancer Institute receives written evidence and argument that the grant would not be consistent with applicable law.
Personalized for You
How does this regulation affect your finances?
Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-20705, Prospective Grant of Exclusive License, Inter-Institutional Agreement-Institution Lead: Antibody Specifically Binding to Severe Fever With Thrombocytopenia Syndrome Virus Antigen and Use Thereof
The National Institute of Allergy and Infectious Diseases plans to give Korea National Institute of Health an exclusive license to develop and sell a special antibody that targets a dangerous virus causing severe fever and low platelets. This deal helps speed up turning the invention into real-world treatments. Comments or license requests must be sent by October 26, 2026.
2026-20771, Center for Scientific Review; Notice of Closed Meetings
The Center for Scientific Review at the NIH is holding several closed virtual meetings in early November 2026 to review and evaluate grant applications. These meetings protect private info and trade secrets, affecting researchers seeking funding. No direct money changes are announced, but these reviews decide who gets research grants.
2026-20424, National Cancer Institute; Notice of Meeting
The President's Cancer Panel is holding a free virtual meeting on October 15, 2026, to talk about how GLP-1 medications can help lower cancer risks linked to obesity. Anyone interested can join online or send in comments beforehand. This meeting is a great chance for patients, doctors, and researchers to learn about new ways to fight cancer and improve health.
2026-20365, Center For Scientific Review; Notice of Closed Meetings
The NIH's Center for Scientific Review is holding several closed virtual meetings on October 29-30, 2026, to review and evaluate grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists applying for grants in areas like biochemistry, software engineering, and mental health will be affected, with no direct money changes announced but important decisions coming soon.
2026-20151, Notice of NIH Tribal Consultations and Listening Session
The NIH is inviting Tribal leaders and members to join two important meetings and a listening session during the National Congress of American Indians Annual Convention in October 2026. They’ll talk about new health research projects, renewing support for Tribal health centers, and shaping a new Tribal Data Sovereignty Policy. Tribes can also send their thoughts by November 20, 2026, helping shape future health programs and policies.
2026-19718, Center for Scientific Review; Notice of Closed Meetings
The NIH’s Center for Scientific Review is holding two closed virtual meetings in October 2026 to review important grant applications. These meetings protect private info and trade secrets while deciding which research projects get funding. Scientists and research teams applying for grants should note these dates as they impact funding decisions but don’t involve public attendance.
Previous / Next Documents
Previous: 2025-20289, Recertification of Cook Inlet Regional Citizens' Advisory Council
The Coast Guard has officially renewed the Cook Inlet Regional Citizens' Advisory Council (CIRCAC) for another year, from September 1, 2025, to August 31, 2026. This group keeps an eye on oil activities in Cook Inlet, Alaska, and since there were no big changes in their latest application, their recertification was smooth and quick. Local communities and environmental watchers can keep counting on CIRCAC’s watchful role without any new fees or delays.
Next: 2025-20291, Agency Information Collection Activities: Comment Request on Burden Related to Superfund; Imported Substances; Procedures for Filing a Petition
The IRS wants your thoughts on how hard it is to ask if certain imported substances should be taxed or not under Superfund rules. This affects businesses dealing with these substances and could change how paperwork is handled, possibly saving time and money. Make sure to send your comments by January 20, 2026, to help shape the process!